Neuromuscular recovery from botulism involves multiple forms of compensatory plasticity

Area of Science:

• Neuroscience
• Toxicology
• Muscle Physiology

Background:

• Botulinum neurotoxin (BoNT) causes neuroparalytic disease by blocking neuromuscular transmission.
• Current treatment for botulism is supportive care, with recovery taking weeks to months.
• The diaphragm neuromuscular junction (NMJ) is a critical target, but its recovery is poorly understood.

Purpose of the Study:

• To develop a low-mortality mouse model for studying botulism-induced respiratory muscle paralysis and recovery.
• To longitudinally analyze the neurophysiological mechanisms of diaphragm recovery after BoNT intoxication.

Main Methods:

• Systemic administration of BoNT/A to mice to induce partial respiratory paralysis.
• Assessment of physiological signs, muscle contraction strength, and neurophysiological parameters (EPP, QC, mEPP frequency).
• Pharmacological inhibition of voltage-gated calcium channels (VGCCs) to investigate their role in recovery.

Main Results:

• Intoxicated mice showed persistent respiratory depression and reduced muscle strength, with functional recovery by 21 days.
• Neurophysiological parameters like quantal content (QC) and miniature EPP (mEPP) frequency remained depressed longer than muscle function.
• N-type and P/Q-type VGCCs partially restored QC, suggesting their role in differential recovery of evoked vs. spontaneous release.

Conclusions:

• BoNT intoxication triggers compensatory plasticity at the NMJ, including increased depolarization and quantal size.
• Differential recovery of evoked release (QC) versus spontaneous release (mEPP frequency) is observed.
• Understanding these recovery mechanisms may lead to novel host-targeted treatments for neuromuscular diseases.